What does the company do?
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. Johnson & Johnson has more than 250 operating companies. The Company operates in three segments. The Consumer segment includes a range of products used in the baby care, skin care, oral care, wound care and women’s healthcare fields, as well as nutritional and over-the-counter pharmaceutical products. The Pharmaceutical segment includes products in the therapeutic areas, such as anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology and virology. The Medical Devices and Diagnostics segment includes a range of products distributed to wholesalers, hospitals and retailers. In July 2009, Johnson & Johnson completed the acquisition of Cougar Biotechnology, Inc. with approximately 95.9% interest in Cougar Biotechnology's outstanding common stock.
How much does the company sell and earn?
Investors need to know how much stuff or services a company sells, and how much of that total it keeps as income (or profit) to grow its business or return to shareholders. The more of each, the better. In general, look for companies that sell and earn more than peers.
- Johnson&Johnson one-year sales: 60.53 Bil.
Difference from the average for the Drug Manufacturers - Major group: 44.64% - Johnson&Johnson one-year income: 12.77 Bil.
Difference from the average for the Drug Manufacturers - Major group: 71.30%| Sales & Income (past 12 months) | Company | Industry |
|---|
| Sales | 60.53 Bil | 41.85 Bil | | Income | 12.77 Bil | 7.46 Bil |
How fast is the company growing?
- Johnson&Johnson one-year sales growth: -6.60%.
- Johnson&Johnson one-year income growth: -1.70%.
| Sales & Income Growth (past 12 months) | Company | Industry |
|---|
| Sales Growth | -6.60% | 1.40% | | Income Growth | -1.70% | 5.30% |
How profitable is the company?
Investors prefer companies that increase profit margins -- the percentage of sales that they keep -- every year. This is accomplished either by lowering expenses or raising prices. Look for companies that consistently find ways to squeeze more profits out of sales than their peers.
- Johnson&Johnson one-year net profit margin: 21.1%
Difference from the company's 5-year average net profit margin: 2.0 pct. pts.
Difference from the average for the Drug Manufacturers - Major group: 2.4 pct. pts.
| Net profit margins (%) |
|---|
| Company | 21.1% | | Company 5-Yr Avg. | 19.1% | | Industry | 18.7% |
How is the company's financial health?
The debt/equity ratio shows how much a firm has borrowed as a percentage of its stock equity. The lower, the better.
- Johnson&Johnson debt/equity ratio: 0.23.
Difference from the average for the Drug Manufacturers - Major group: -89.87%.
| | Company | Industry |
|---|
| Debt/equity ratio | 0.23 | 2.27 |
|
Recent News